
Lisa Yelland
School of Public Health
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Associate Professor Lisa Yelland is a Biostatistician Senior Research Fellow in the Women and Kids Theme and Co-Leader of the Biostatistics Unit at the South Australian Health and Medical Research Institute. She is also an Affiliate Associate Professor in the School of Public Health at The University of Adelaide. As a biostatistician and clinical trialist specializing in maternal and infant health, her research broadly aims to drive improvements in the health of mothers, babies and other populations by using innovative statistical approaches to improve trial design and analysis. She is currently investigating methods for designing and analysing clinical trials collecting partially clustered data, and methods for addressing imperfect stratification in the analysis of trials that utilise stratified randomisation.
-
Journals
Year Citation 2025 Psaltis, P. J., Nguyen, M. T., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., . . . Nicholls, S. J. (2025). Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research, 121(3), 468-478.
Scopus11 Europe PMC82025 Robledo, K. P., Libesman, S., & Yelland, L. N. (2025). We should do better in accounting for multiple births in neonatal randomised trials: a methodological systematic review. Archives of Disease in Childhood: Fetal and Neonatal Edition, 110(4), F362-F368.
Scopus1 Europe PMC12025 Shepherd, E., McIntyre, S., Rumbold, A., Karim, T., Goldsmith, S., Keir, A., . . . Yelland, L. (2025). Increasing Use of Antenatal Magnesium Sulphate Prior to Preterm Birth for Preventing Cerebral Palsy in Australia and New Zealand, 2012–2020: A Binational Registry Study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 13937-1-13937-5.
2025 Robledo, K. P., Libesman, S., & Yelland, L. N. (2025). Accounting for twins in statistical analyses could change conclusions. European Journal of Pediatrics, 184(5), 2 pages.
2025 Lange, K. M., Kasza, J., Sullivan, T. R., & Yelland, L. N. (2025). Sample Size Calculations for Partially Clustered Trials. Statistics in Medicine, 44(15-17), e70172.
2024 Lange, K. M., Sullivan, T. R., Kasza, J., & Yelland, L. N. (2024). Performance of mixed effects models and generalized estimating equations for continuous outcomes in partially clustered trials including both independent and paired data. Statistics in Medicine, 43(25), 4819-4835.
Scopus2 Europe PMC12024 Sullivan, T. R., Morris, T. P., Kahan, B. C., Cuthbert, A. R., & Yelland, L. N. (2024). Categorisation of continuous covariates for stratified randomisation: How should we adjust?. Statistics in Medicine, 43(11), 2083-2095.
Scopus6 Europe PMC52024 Gould, J. F., Cuthbert, A. R., Yelland, L. N., Gibson, R. A., Smithers, L. G., Zhou, S. J., & Makrides, M. (2024). Association of cord blood vitamin D with child neurodevelopment at 7 years of age. Journal of Paediatrics and Child Health, 60(7), 312-322.
Scopus12024 Gould, J. F., Gibson, R. A., Yelland, L. N., Colombo, J., McPhee, A. J., Gallier, S., . . . Makrides, M. (2024). Infant formula supplemented with milk fat globule membrane compared with standard infant formula for the cognitive development of healthy term-born formula-fed infants: protocol for a randomised controlled trial. BMJ Open, 14(6), e083399-1-e083399-13.
Scopus22023 Yelland, L. N., Sullivan, T. R., Gibson, R. A., Simmonds, L. A., Thakkar, S. K., Huang, F., . . . Makrides, M. (2023). Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.. BMJ Open, 13(4), e070220.
Scopus4 Europe PMC52023 Best, K. P., Yelland, L. N., Collins, C. T., McPhee, A. J., Rogers, G. B., Choo, J., . . . Makrides, M. (2023). Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trial.. Frontiers in pediatrics, 11, 1146089.
Europe PMC12023 Yelland, L. N., Louise, J., Kahan, B. C., Morris, T. P., Lee, K. J., & Sullivan, T. R. (2023). Handling misclassified stratification variables in the analysis of randomised trials with continuous outcomes. Statistics in Medicine, 42(19), 1-18.
Scopus5 WoS1 Europe PMC32023 Sullivan, T. R., Yelland, L. N., Gibson, R. A., Thakkar, S. K., Huang, F., Best, K. P., . . . Makrides, M. (2023). Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trial. BMJ Open, 13(9), e076507-1-e076507-8.
Scopus1 Europe PMC12023 Lange, K. M., Kasza, J., Sullivan, T. R., & Yelland, L. N. (2023). Partially clustered designs for clinical trials: Unifying existing designs using consistent terminology. Clinical Trials, 20(2), 99-110.
Scopus10 WoS2 Europe PMC72022 Yelland, L. N., Scurrah, K. J., Ferreira, P., Calais-Ferreira, L., Rankin, M., Denton, J., . . . Craig, J. M. (2022). Conducting clinical trials in twin populations: a review of design, analysis, recruitment and ethical issues for twin-only trials. Twin Research and Human Genetics, 24(6), 359-364.
Scopus3 Europe PMC62022 Gibson, R. A., Makrides, M., Sullivan, T., Yelland, L. N., & Best, K. P. (2022). Response to Jackson and Harris, 2022;179:102417. Prostaglandins, Leukotrienes and Essential Fatty Acids, 182, 102454-1-102454-2.
Scopus1 Europe PMC12022 Gould, J. F., Yelland, L. N., Gibson, R. A., McPhee, A. J., Varghese, J., Grivell, R., & Makrides, M. (2022). Protocol for a multicentre prospective observational study of families with full-term infants on postnatal wards and in the community to capture feeding practices across the first year of life: the Mother Infant Lactation Questionnaire (MILQ) study. BMJ Open, 12(10), e066355-1-e066355-6.
Scopus2 Europe PMC22021 Chan, K., Gallant, J., Leemaqz, S., Baldwin, D. A., Borath, M., Kroeun, H., . . . Whitfield, K. C. (2021). Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia. Annals of the New York Academy of Sciences, 1498(1), 85-95.
Scopus12 WoS5 Europe PMC102021 Wassie, M. M., Smithers, L. G., Yelland, L. N., Makrides, M., & Zhou, S. J. (2021). Associations between newborn thyroid stimulating hormone concentration and neurodevelopment and growth of children at 18 months. The British Journal of Nutrition, 126(10), 1478-1488.
Scopus4 Europe PMC32021 Gallant, J., Chan, K., Green, T. J., Wieringa, F. T., Leemaqz, S., Ngik, R., . . . Whitfield, K. C. (2021). Low-dose thiamine supplementation of lactating Cambodian mothers improves human milk thiamine concentrations: a randomized controlled trial. American Journal of Clinical Nutrition, 114(1), 90-100.
Scopus16 WoS6 Europe PMC142021 Sullivan, T. R., Yelland, L. N., Moreno-Betancur, M., & Lee, K. J. (2021). Multiple imputation for handling missing outcome data in randomized trials involving a mixture of independent and paired data. Statistics in Medicine, 40(27), 6008-6020.
Scopus6 WoS4 Europe PMC62021 Gould, J. F., Anderson, P. J., Yelland, L. N., Gibson, R. A., & Makrides, M. (2021). The influence of Prenatal DHA supplementation on individual domains of behavioral functioning in school‐aged children: Follow‐up of a randomized controlled trial. Nutrients, 13(9), 2996-1-2996-20.
Scopus4 WoS2 Europe PMC32021 Simmonds, L. A., Yelland, L. N., Best, K. P., Liu, G., Gibson, R. A., & Makrides, M. (2021). Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy: Translating n-3 status across blood fractions in pregnancy.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 176, 102367.
Scopus9 WoS6 Europe PMC42020 Ramsden, C. E., Makrides, M., Yuan, Z. -X., Horowitz, M. S., Zamora, D., Yelland, L. N., . . . Gibson, R. A. (2020). Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: can they help predict risk of preterm birth?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 153, 102041-1-102041-9.
Scopus20 WoS15 Europe PMC132020 Simmonds, L. A., Sullivan, T. R., Skubisz, M., Middleton, P. F., Best, K. P., Yelland, L. N., . . . Makrides, M. (2020). Omega-3 fatty acid supplementation in pregnancy - baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 127(8), 975-981.
Scopus72 WoS45 Europe PMC452020 Samson, K. L. I., Loh, S. P., Khor, G. L., Mohd Shariff, Z., Yelland, L. N., Leemaqz, S., . . . Karakochuk, C. D. (2020). Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in Malaysia.. BMJ open, 10(2), e034598.
Scopus8 WoS4 Europe PMC42020 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2020). A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery. Obstetrical and Gynecological Survey, 75(2), 79-80.
2020 Hewawasam, E., Collins, C. T., Muhlhausler, B. S., Yelland, L. N., Smithers, L. G., Colombo, J. C., . . . Gould, J. F. (2020). Docosahexaenoic acid supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial. The British Journal of Nutrition, 125(4), 1-26.
Scopus20 WoS10 Europe PMC142020 Best, K. P., Gibson, R. A., Yelland, L. N., Leemaqz, S., Gomersall, J., Liu, G., & Makrides, M. (2020). Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy. Prostaglandins Leukot Essent Fatty Acids, 162, 102181-1-102181-9.
Scopus7 WoS6 Europe PMC42020 Gawlik, N. R., Makrides, M., Kettler, L., Yelland, L. N., Leemaqz, S., & Gould, J. F. (2020). The influence of DHA supplementation during pregnancy on language development across childhood: follow-up of a randomised controlled trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 163, 102207-1-102207-12.
Scopus3 WoS2 Europe PMC22020 Samson, K. L. I., Loh, S. P., Lee, S. S., Sulistyoningrum, D. C., Khor, G. L., Shariff, Z. B. M., . . . Green, T. J. (2020). Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.. BMJ Glob Health, 5(12), 1-9.
Scopus12 WoS8 Europe PMC42019 Whitfield, K. C., Kroeun, H., Green, T., Wieringa, F. T., Borath, M., Sophonneary, P., . . . Gallant, J. (2019). Thiamine dose response in human milk with supplementation among lactating women in Cambodia: study protocol for a double-blind, four-parallel arm randomised controlled trial. BMJ Open, 9(7), e029255-1-e029255-9.
Scopus10 WoS6 Europe PMC62019 Wassie, M. M., Yelland, L. N., Smithers, L. G., Ranieri, E., & Zhou, S. J. (2019). Comparison of iodine status pre- and post-mandatory iodine fortification of bread in South Australia: a population study using newborn thyroid-stimulating hormone concentration as a marker. Public Health Nutrition, 22(16), 3063-3072.
Scopus4 WoS4 Europe PMC42019 Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2019). A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. The New England journal of medicine, 381(11), 1035-1045.
Scopus78 WoS52 Europe PMC462018 Sumathipala, A., Yelland, L., Green, D., Shepherd, T., Jayaweera, K., Ferreira, P., & Craig, J. (2018). Twins as participants in randomized controlled trials: a review of published literature. Twin Research and Human Genetics, 21(1), 51-56.
Scopus11 WoS7 Europe PMC72018 Dodd, J., McPhee, A., Deussen, A., Louise, J., Yelland, L., Owens, J., & Robinson, J. (2018). Effects of an antenatal dietary intervention in overweight and obese women on 6 month infant outcomes: follow-up from the LIMIT randomised trial. International Journal of Obesity, 42(7), 1326-1335.
Scopus22 WoS21 Europe PMC152018 Yelland, L., Kahan, B., Dent, E., Lee, K., Voysey, M., Forbes, A., & Cook, J. (2018). Prevalence and reporting of recruitment, randomisation and treatment errors in clinical trials: a systematic review. Clinical Trials, 15(3), 278-285.
Scopus17 WoS10 Europe PMC132018 Yelland, L., Sullivan, T., Collins, C., Price, D., Mcphee, A., & Lee, K. (2018). Accounting for twin births in sample size calculations for randomised trials. Paediatric and Perinatal Epidemiology, 32(4), 380-387.
Scopus13 WoS7 Europe PMC92018 Yelland, L. N., Schuit, E., Zamora, J., Middleton, P. F., Lim, A. C., Nassar, A. H., . . . Gates, S. (2018). Correlation between neonatal outcomes of twins depends on the outcome: secondary analysis of twelve randomised controlled trials. BJOG, 125(11), 1406-1413.
Scopus9 WoS5 Europe PMC92017 Lei, Y., Carlson, S., Yelland, L., Makrides, M., Gibson, R., & Gajewski, B. (2017). Comparison of dichotomized and distributional approaches in rare event clinical trial design: a fixed Bayesian design. Journal of Applied Statistics, 44(8), 1466-1478.
Scopus5 WoS3 Europe PMC32017 Gould, J. F., Anderson, A. J., Yelland, L. N., Smithers, L. G., Skeaff, C. M., Zhou, S. J., . . . Makrides, M. (2017). Association of cord blood vitamin D with early childhood growth and neurodevelopment. Journal of Paediatrics and Child Health, 53(1), 75-83.
Scopus50 WoS35 Europe PMC382017 Yelland, L., Sullivan, T., Price, D., & Lee, K. (2017). Sample size calculations for randomised trials including both independent and paired data. Statistics in Medicine, 36(8), 1227-1239.
Scopus20 WoS13 Europe PMC152017 Moran, L., Fraser, L., Sundernathan, T., Deussen, A., Louise, J., Yelland, L., . . . Dodd, J. (2017). The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Medicine, 15(1), 1-12.
Scopus16 WoS15 Europe PMC152017 Gould, J., Treyvaud, K., Yelland, L., Anderson, P., Smithers, L., McPhee, A., & Makrides, M. (2017). Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA, 317(11), 1173-1175.
Scopus48 WoS37 Europe PMC292017 Sullivan, T., Yelland, L., Lee, K., Ryan, P., & Salter, A. (2017). Treatment of missing data in follow-up studies of randomised controlled trials: a systematic review of the literature. Clinical Trials, 14(4), 387-395.
Scopus26 WoS19 Europe PMC132017 Dodd, J., Du Plessis, L., Deussen, A., Grivell, R., Yelland, L., Louise, J., . . . Owens, J. (2017). Paternal obesity modifies the effect of an antenatal lifestyle intervention in women who are overweight or obese on newborn anthropometry. Scientific Reports, 7(1), 1557-1-1557-9.
Scopus8 WoS8 Europe PMC52017 Zhou, S., Best, K., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., & Makrides, M. (2017). Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial. BMJ Open, 7(9), e018360-1-e018360-9.
Scopus18 WoS19 Europe PMC142016 Yelland, L., Gajewski, B., Colombo, J., Gibson, R., Makrides, M., & Carlson, S. (2016). Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins Leukotrienes and Essential Fatty Acids, 112, 44-49.
Scopus23 WoS18 Europe PMC192016 Dodd, J., Newman, A., Moran, L., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2016). The effect of antenatal dietary and lifestyle advice for women who are overweight or obese on emotional well-being: the LIMIT randomized trial. Acta Obstetricia et Gynecologica Scandinavica, 95(3), 309-318.
Scopus28 WoS21 Europe PMC262016 Grivell, R., Yelland, L., Deussen, A., Crowther, C., & Dodd, J. (2016). Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 233-243.
Scopus33 WoS26 Europe PMC222016 Dodd, J., Deussen, A., Mohamad, I., Rifas-Shiman, S., Yelland, L., Louise, J., . . . Robinson, J. (2016). The effect of antenatal lifestyle advice for women who are overweight or obese on secondary measures of neonatal body composition: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 244-253.
Scopus28 WoS24 Europe PMC232016 Yelland, L. N., Sullivan, T. R., Pavlou, M., & Seaman, S. R. (2016). Response to Klebanoff. Paediatric and Perinatal Epidemiology, 30(2), 206.
2016 Yelland, L., Makrides, M., McPhee, A., Quinlivan, J., & Gibson, R. (2016). Importance of adequate sample sizes in fatty acid intervention trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 107, 8-11.
Scopus7 WoS6 Europe PMC52016 Muhlhausler, B., Yelland, L., McDermott, R., Tapsell, L., McPhee, A., Gibson, R., & Makrides, M. (2016). DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to Optimize Mother Infant Outcome randomized controlled trial. American Journal of Clinical Nutrition, 103(6), 1489-1496.
Scopus42 WoS38 Europe PMC312016 Gould, J., Anderson, A., Yelland, L., Gibson, R., & Makrides, M. (2016). Maternal characteristics influence response to DHA during pregnancy. Prostaglandins, Leukotrienes and Essential Fatty Acids, 108, 5-12.
Scopus15 WoS11 Europe PMC102016 Gould, J. F., Treyvaud, K., Yelland, L. N., Anderson, P. J., Smithers, L. G., Gibson, R. A., . . . Makrides, M. (2016). Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial. BMJ Open, 6(5), e011465-1-e011465-9.
Scopus17 WoS15 Europe PMC102016 van Dijk, S., Zhou, J., Peters, T., Buckley, M., Sutcliffe, B., Oytam, Y., . . . Muhlhausler, B. (2016). Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trial. Clinical Epigenetics, 8(1), 114-1-114-13.
Scopus74 WoS50 Europe PMC502015 Martin, K. E., Grivell, R. M., Yelland, L. N., & Dodd, J. M. (2015). The influence of maternal BMI and gestational diabetes on pregnancy outcome. Diabetes Research and Clinical Practice, 108(3), 508-513.
Scopus67 WoS63 Europe PMC492015 Yelland, L., Sullivan, T., Voysey, M., Lee, K., Cook, J., & Forbes, A. (2015). Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clinical Trials, 12(4), 418-423.
Scopus54 WoS53 Europe PMC402015 Gould, J., Anderson, A., Yelland, L., Smithers, L., Skeaff, C., Gibson, R., & Makrides, M. (2015). Association of cord blood vitamin D at delivery with postpartum depression in Australian women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 55(5), 446-452.
Scopus26 WoS21 Europe PMC142015 Dodd, J., Kannieappan, L., Grivell, R., Deussen, A., Moran, L., Yelland, L., & Owens, J. (2015). Effects of an antenatal dietary intervention on maternal anthropometric measures in pregnant women with obesity. Obesity, 23(8), 1555-1562.
Scopus14 WoS11 Europe PMC102015 Dodd, J. M., Ahmed, S., Karnon, J., Umberger, W., Deussen, A. R., Tran, T., . . . Robinson, J. S. (2015). The cost-effectiveness of providing antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMC Obesity, 2(1), 14-1-14-9.
Scopus17 Europe PMC152015 Yelland, L., Sullivan, T., Pavlou, M., & Seaman, S. (2015). Analysis of randomised trials including multiple births when birth size is informative. Paediatric and Perinatal Epidemiology, 29(6), 567-575.
Scopus24 WoS19 Europe PMC212015 Zhou, S., Skeaff, S., Ryan, P., Doyle, L., Anderson, P., Kornman, L., . . . Makrides, M. (2015). The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial. Trials, 16(1), 563-1-563-9.
Scopus48 WoS33 Europe PMC292015 Yelland, L. N., Sullivan, T. R., & Makrides, M. (2015). Accounting for multiple births in randomised trials: a systematic review. Archives of Disease in Childhood. Fetal and Neonatal Edition, 100(2), 116-120.
Scopus19 WoS16 Europe PMC162014 Szmeja, M., Cramp, C., Grivell, R., Deussen, A., Yelland, L., & Dodd, J. (2014). Use of a DVD to provide dietary and lifestyle information to pregnant women who are overweight or obese: a nested randomised trial. BMC Pregnancy and Childbirth, 14(1), 409-1-409-11.
Scopus24 WoS18 Europe PMC182014 Dodd, J., Cramp, C., Sui, Z., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Medicine, 12(1), 161-1-161-19.
Scopus143 WoS127 Europe PMC1062014 Dodd, J., McPhee, A., Turnbull, D., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Medicine, 12(1), 163-1-163-9.
Scopus73 WoS66 Europe PMC592014 Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ, 348(3), 1-12.
Scopus419 WoS330 Europe PMC3132014 Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. Obstetrical and Gynecological Survey, 69(6), 311-313.
Scopus3 WoS22014 Bain, E., Middleton, P., Yelland, L., Ashwood, P., & Crowther, C. (2014). Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial. BJOG, 121(5), 595-603.
Scopus11 WoS9 Europe PMC52014 Muhlhausler, B., Gibson, R., Yelland, L., & Makrides, M. (2014). Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins, leukotrienes, and essential fatty acids, 91(4), 135-140.
Scopus25 WoS21 Europe PMC132014 Makrides, M., Gould, J., Gawlik, N., Yelland, L., Smithers, L., Anderson, P., & Gibson, R. (2014). Four-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA: Journal of the American Medical Association, 311(17), 1802-1804.
Scopus72 WoS55 Europe PMC432013 Kannieappan, L., Deussen, A., Grivell, R., Yelland, L., & Dodd, J. (2013). Developing a tool for obtaining maternal skinfold thickness measurements and assessing inter-observer variability among pregnant women who are overweight and obese. BMC Pregnancy and Childbirth, 13(1), 42-48.
Scopus37 WoS26 Europe PMC262013 Tu, W., Muhlhausler, B., Yelland, L., & Gibson, R. (2013). Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins Leukotrienes and Essential Fatty Acids, 88(1), 53-60.
Scopus48 WoS40 Europe PMC362012 Crowther, C., Aghajafari, F., Askie, L., Asztalos, E., Brocklehurst, P., Bubner, T., . . . Zhang, Y. (2012). Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol. Systematic Reviews, 1(12), 1-10.
Scopus17 WoS16 Europe PMC112012 Piteo, A., Yelland, L., & Makrides, M. (2012). Does maternal depression predict developmental outcome in 18 month old infants?. Early Human Development, 88(8), 651-655.
Scopus51 WoS40 Europe PMC362012 Zhou, S., Yelland, L., McPhee, A., Quinlivan, J., Gibson, R., & Makrides, M. (2012). Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition, 95(6), 1378-1384.
Scopus120 WoS90 Europe PMC762012 Crowther, C., Hague, W., Middleton, P., Baghurst, P., McPhee, A., Tran, T., . . . Robinson, J. (2012). The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial - study protocol. BMC Pregnancy and Childbirth, 12(106), 2-8.
Scopus16 WoS13 Europe PMC82011 Makrides, M., Yelland, L., & Gibson, R. (2011). Maternal depression and child development after prenatal DHA supplementation: Reply. JAMA - Journal of the American Medical Association, 305(4), 360-361.
Europe PMC42011 Yelland, L., Salter, A., & Ryan, P. (2011). Performance of the modified poisson regression approach for estimating relative risks from clustered prospective data. American Journal of Epidemiology, 174(8), 984-992.
Scopus345 WoS263 Europe PMC3162011 Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in randomized controlled trials: A comparison of methods for independent observations. The International Journal of Biostatistics, 7(1), 2-33.
Scopus32 WoS372011 Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in cluster randomized trials: A comparison of generalized estimating equation methods. The International Journal of Biostatistics, 7(1), 2-28.
Scopus16 WoS22011 Yelland, L., Salter, A., Ryan, P., & Makrides, M. (2011). Analysis of binary outcomes from randomised trials including multiple births: when should clustering be taken into account?. Paediatric and Perinatal Epidemiology, 25(3 Sp Iss), 283-297.
Scopus25 WoS19 Europe PMC232011 Yelland, L., Salter, A., Ryan, P., & Laurence, C. (2011). Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care. Clinical Trials, 8(1), 48-58.
Scopus33 WoS26 Europe PMC272010 Makrides, M., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., Ryan, P., . . . Griffith, E. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. Jama-journal of the American Medical Association, 304(15), 1675-1683.
Scopus476 WoS394 Europe PMC3352010 Yelland, L., Gialamas, A., Laurence, C., Willson, K., Ryan, P., Beilby, J., . . . Worley, P. (2010). Assessing agreement between point of care and pathology laboratory results for INR: experiences from the Point of Care Testing in General Practice Trial. Pathology, 42(2), 155-159.
Scopus8 WoS7 Europe PMC52010 Gialamas, A., Laurence, C., Yelland, L., Tideman, P., Worley, P., Shephard, M., . . . Beilby, J. (2010). Assessing agreement between point of care and laboratory results for lipid testing from a clinical perspective. Clinical Biochemistry, 43(4-5), 515-518.
Scopus17 WoS16 Europe PMC152010 Laurence, C., Gialamas, A., Bubner, T., Yelland, L., Willson, K., Ryan, P., . . . Worley, P. (2010). Patient satisfaction with point-of-care testing in general practice. British Journal of General Practice, 60(572), 166-171.
Scopus57 WoS67 Europe PMC622010 Makrides, M., Gibson, R. A., McPhee, A. J., Yelland, L., Quinlivan, J., & Ryan, P. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial (1). Revista Chilena De Obstetricia Y Ginecologia, 75(6), 422-424. 2009 Gialamas, A., Yelland, L., Ryan, P., Willson, K., Laurence, C., Bubner, T., . . . Beilby, J. (2009). Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Medical Journal of Australia, 191(9), 487-491.
Scopus70 WoS64 Europe PMC522009 Bubner, T., Laurence, C., Gialamas, A., Yelland, L., Ryan, P., Willson, K., . . . Beilby, J. (2009). Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Medical Journal of Australia, 190(11), 624-626.
Scopus61 WoS57 Europe PMC392009 Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2009). Erratum: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - Rationale, design and baseline characteristics (Trials)). Trials, 10(1), 3 pages.
2008 Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2008). A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials, 9(50), www1-www14.
Scopus41 WoS45 Europe PMC302008 Yelland, L., Burns, J., Sims, N., Salter, A., & White, J. (2008). Inter- and intra-subject variability in ethanol pharmacokinetic parameters: effects of testing interval and dose.. Forensic Science International, 175(1), 65-72.
Scopus12 WoS8 Europe PMC42007 Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Matin, D., Gialamas, A., & Beilby, J. (2007). A before and after study of the impact of academic detailing on the use of diagnostic imaging for shoulder complaints in general practice. BMC Family Practice, 8(1), WWW 1-WWW 8.
Scopus16 WoS14 Europe PMC102007 Breed, W., Bauer, M., Wade, R., Thitipramote, N., Suwajarat, J., & Yelland, L. (2007). Intra-individual variation in sperm tail length in murine rodents. Journal of Zoology, 272(3), 299-304.
Scopus23 WoS202006 Broadhurst, N., Barton, C., Yelland, L., Martin, D., & Beilby, J. (2006). Managing shoulder pain in general practice: The value of academic detailing. Australian Family Physician, 35(9), 751-752.
Scopus9 Europe PMC62006 Nelson, M., Reid, C., Ryan, P., Willson, K., & Yelland, L. (2006). Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Medical Journal of Australia, 185(9), 487-489.
Scopus104 WoS89 Europe PMC722006 Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Martin, D., Gialamas, A., & Beilby, J. (2006). Academic detailing and informed use of imaging of the shoulder in general practice. Australasian Musculoskeletal Medicine, 11(1), 28-35. 2005 Barnden, L., Behin-Ain, S., Kwiatek, R., Casse, R., & Yelland, L. (2005). Age related preservation and loss in optimized brain SPECT. Nuclear Medicine Communications, 26(6), 497-503.
Scopus12 WoS8 Europe PMC7 -
Conference Papers
Year Citation 2022 Best, K., Yelland, L., Gibson, R., & Makrides, M. (2022). Omega-3 to Reduce the Incidence of Preterm Birth - from bench to bedside. In WOMEN AND BIRTH Vol. 35 (pp. S42). ELSEVIER.
2006 Breed, W., Bauer, M., Wade, R., Thitipramote, N., Suwajarat, J., & Yelland, L. (2006). Intraspecific variation in sperm head shape and tail length in murine rodents. In American Society of Mammalogists 86th Annual Meeting (pp. Abstract no 12). Amherst, Massachusetts, USA. 2006 Breed, W., Bauer, M., Wade, R., Thitipramote, N., Suwajarat, J., & Yelland, L. (2006). Intraspecific variation in sperm tail length in rodents. In Society for Reproduction and Fertility Conference 2006 and National Ovarian Workshop Programme & Abstract Book (pp. 32). Leeds. -
Conference Items
Year Citation - Lange, K., Sullivan, T. R., Kasza, J., & Yelland, L. (n.d.). Performance of mixed effects models for partially clustered trials. Poster session presented at the meeting of Unknown Conference.
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2025 Principal Supervisor Statistical Issues in Childhood Follow-up Studies of Randomised Trials Doctor of Philosophy Doctorate Full Time Miss Sareh Roosta -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2021 - 2025 Principal Supervisor Design Issues for Partially Clustered Trials Doctor of Philosophy Doctorate Full Time Ms Kylie Lange 2017 - 2020 Co-Supervisor Iodine Nutrition in Early Life and Childhood Neurodevelopment and Growth Doctor of Philosophy Doctorate Full Time Mr Molla Mesele Wassie 2014 - 2016 Co-Supervisor Analysis of Longitudinal Data in Perinatal Trials when the Length of Follow-up is Informative Master of Philosophy Master Full Time Miss Tessa Longstaff
Connect With Me
External Profiles